临床医学工程2024，Vol.31Issue(3)：283-284,2.DOI:10.3969/j.issn.1674-4659.2024.03.0283
血必净注射液联合沙库巴曲缬沙坦钠片治疗急性心肌梗死后心力衰竭患者的临床效果
Clinical Effect of Xuebijing Injection Combined with Sacubitril Valsartan Sodium Tablets in the Treatment of Patients with Heart Failure after Acute Myocardial Infarction
卢杏 1张学平 1卢鹏飞 1刘志强1
作者信息
- 1. 新乡市中心医院心血管内科,河南新乡 453000
- 折叠
摘要
Abstract
Objective To explore the clinical effect of Xuebijing injection combined with sacubitril valsartan sodium tablets in the treatment of patients with heart failure after acute myocardial infarction.Methods 76 patients with heart failure after acute myocardial infarction were randomly divided into control group and study group,with 38 cases in each group.Both groups were treated with percutaneous coronary intervention.The control group was treated with sacubitril valsartan sodium tablets,and the study group was treated with Xuebijing injection combined with sacubitril valsartan sodium tablets.The cardiac function indicators and adverse reactions were compared between the two groups.Results After 12 days of treatment,the left ventricular ejection fraction(LVEF)of the study group was higher than that of the control group,and the N-terminal pro-brain natriuretic peptide(NT-proBNP)level was lower than that of the control group(P＜0.05).During the treatment,no statistical difference was found in the incidence of adverse reactions(10.53％ vs.13.16％)between the two groups(P＞0.05).Conclusions Xuebijing injection combined with sacubitril valsartan sodium tablets in the treatment of heart failure after acute myocardial infarction can significantly improve the cardiac function of patients with higher safety.关键词
急性心肌梗死后心力衰竭/沙库巴曲缬沙坦钠片/血必净注射液/心功能/不良反应Key words
Heart failure after acute myocardial infarction/Sacubitril valsartan sodium tablets/Xuebijing injection/Cardiac function/Adverse reaction分类
医药卫生引用本文复制引用
卢杏,张学平,卢鹏飞,刘志强..血必净注射液联合沙库巴曲缬沙坦钠片治疗急性心肌梗死后心力衰竭患者的临床效果[J].临床医学工程,2024,31(3):283-284,2.
